166 related articles for article (PubMed ID: 14690593)
21. Kinase activation through dimerization by human SH2-B.
Nishi M; Werner ED; Oh BC; Frantz JD; Dhe-Paganon S; Hansen L; Lee J; Shoelson SE
Mol Cell Biol; 2005 Apr; 25(7):2607-21. PubMed ID: 15767667
[TBL] [Abstract][Full Text] [Related]
22. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
Liu SK; McGlade CJ
Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
[TBL] [Abstract][Full Text] [Related]
23. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
24. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
25. pH-Dependent self-association of the Src homology 2 (SH2) domain of the Src homologous and collagen-like (SHC) protein.
Réty S; Fütterer K; Grucza RA; Munoz CM; Frazier WA; Waksman G
Protein Sci; 1996 Mar; 5(3):405-13. PubMed ID: 8868476
[TBL] [Abstract][Full Text] [Related]
26. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor.
Eck MJ; Dhe-Paganon S; Trüb T; Nolte RT; Shoelson SE
Cell; 1996 May; 85(5):695-705. PubMed ID: 8646778
[TBL] [Abstract][Full Text] [Related]
27. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor.
Zhou MM; Meadows RP; Logan TM; Yoon HS; Wade WS; Ravichandran KS; Burakoff SJ; Fesik SW
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7784-8. PubMed ID: 7544002
[TBL] [Abstract][Full Text] [Related]
28. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
29. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
Ross SA; Lienhard GE; Lavan BE
Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
[TBL] [Abstract][Full Text] [Related]
30. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
31. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
32. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
[TBL] [Abstract][Full Text] [Related]
33. Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.
Schiering N; Casale E; Caccia P; Giordano P; Battistini C
Biochemistry; 2000 Nov; 39(44):13376-82. PubMed ID: 11063574
[TBL] [Abstract][Full Text] [Related]
34. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
35. Distinct Grb10 domain requirements for effects on glucose uptake and insulin signaling.
Mori K; Giovannone B; Smith RJ
Mol Cell Endocrinol; 2005 Jan; 230(1-2):39-50. PubMed ID: 15664450
[TBL] [Abstract][Full Text] [Related]
36. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
[TBL] [Abstract][Full Text] [Related]
37. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
[TBL] [Abstract][Full Text] [Related]
38. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
39. The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor.
Ahmed Z; Smith BJ; Pillay TS
FEBS Lett; 2000 Jun; 475(1):31-4. PubMed ID: 10854852
[TBL] [Abstract][Full Text] [Related]
40. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
